β2-Glycoprotein I-dependent anticardiolipin antibody is reactive to both β2-glycoprotein I/oxidized as well as β2-glycoprotein I/reduced cardiolipin

Thrombosis Research

Volumn 95, Issue 1, 1999, Pages 63-67

  Matsuda, Juzo ^a,b   Gohchi, Kengo ^a   Gotoh, Moritaka ^a   Kawasugi, Kazuo ^a   Katoh, Misaho ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Anticardiolipin antibody; Antiphospholipid antibody; Oxidized phospholipid; Reduced phospholipid

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; EPITOPE; LIPID PEROXIDE; GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANTIBODY SPECIFICITY; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; OXIDATION REDUCTION REACTION;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODY SPECIFICITY; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HUMANS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION;

EID: 0033153767     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00021-3     Document Type: Article

References (17)

1. Mackworth-Young C.G. Antiphospholipid antibodies and disease. Brit J Rheumatol. 34:1995;1009-1030.
2. Triplett P.A. Protean clinical presentation of antiphospholipid-protein antibodies (APA). Thromb Haemostasis. 74:1995;329-337.
3. Shapiro S.S. The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med. 47:1996;533-553.
4. Roubey R.A.S. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 39:1996;1444-1454.
5. Galli M., Comfurius P., Massen C., Hemker H.E., deBaets M.H., van Breda-Vriesman P.J., Barbui T., Zwaal R.F., Bevers E.M. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 335:1990;1544-1551.
6. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA. 87:1990;4120-4124.
7. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 336:1990;177-178.
8. Fleck R.A., Rapaport S.I., Rao L.V.M. Anti-prothrombin antibodies and the lupus anticoagulant. Blood. 72:1988;512-519.
9. Bevers E.M., Galli M., Barbui T., Comfurius P., Zwaal R.F.A. Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to an complex of lipid-bound human prothrombin. Thromb Haemostasis. 66:1991;629-632.
10. Arvieux J., Darnige L., Caron C., Reber G., Bensa J.C., Colomb M.G. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemostasis. 74:1995;1120-1125.
11. Matsuda J., Saitoh N., Gotoh M., Kawasugi K., Gohchi K., Tsukamoto M. Phosphatidyl serine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant. Brit J Rheumatol. 35:1996;589-591.
12. Horkko S., Miller E., Dudl E., Reaven P., Curtiss L.K., Zvaifler N.J., Terkertaub R., Pierangeli S.S., Branch D.W., Palinski W., Witztum J.L. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. Clin Invest. 98:1996;815-825.
13. 2-glycoprotein I (and other proteins). Proc Natl Acad Sci USA. 94:1997;10356-10361.
14. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med. 15:1976;212-216.
15. 2-glycoprote in I dependent (systemic lupus erythematosus type) and independent (syphilis type) anti-cardiolipin antibody with Tween 20. Brit J Haematol. 85:1993;799-802.
16. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med. 179:1994;457-462.
17. 2-glycoprotein I in the absence of phospholipid. Importance of antigen density and bivalent binding J Immunol. 154:1995;954-960.